

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in understanding antiphospholipid... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/5-2908/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/5-2908" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in understanding antiphospholipid syndrome" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in understanding antiphospholipid syndrome.">
            <meta name="og:description" content="Read the latest article version by Maria Laura Bertolaccini, Giovanni Sanna, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="10474">
            <meta name="article-id" content="9717">
            <meta name="dc.title" content="Recent advances in understanding antiphospholipid syndrome">
            <meta name="dc.description" content="Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including the persistent presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and/or anti-b2 glycoprotein I (anti-b2GPI) antibodies of IgG or IgM isotype at medium to high titres in patient&rsquo;s plasma. However, several other autoantibodies targeting other coagulation cascade proteins (i.e. prothrombin) or their complex with phospholipids (i.e. phosphatidylserine/prothrombin complex), or to some domains of &beta;2GPI, have been proposed to be also relevant to APS. In fact, the value of testing for new aPL specificities in the identification of APS in thrombosis and/or pregnancy morbidity patients is currently being investigated.">
            <meta name="dc.subject" content="antiphospholipid syndrome, APS, Hughes Syndrome, ">
            <meta name="dc.creator" content="Bertolaccini, Maria Laura">
            <meta name="dc.creator" content="Sanna, Giovanni">
            <meta name="dc.date" content="2016/12/22">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.9717.1">
            <meta name="dc.source" content="F1000Research 2016 5:2908">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="antiphospholipid syndrome">
            <meta name="prism.keyword" content=" APS">
            <meta name="prism.keyword" content=" Hughes Syndrome">
            <meta name="prism.keyword" content=" ">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2016/12/22">
            <meta name="prism.volume" content="5">
            <meta name="prism.number" content="2908">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.9717.1">
            <meta name="prism.url" content="https://f1000research.com/articles/5-2908">
            <meta name="citation_title" content="Recent advances in understanding antiphospholipid syndrome">
            <meta name="citation_abstract" content="Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including the persistent presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and/or anti-b2 glycoprotein I (anti-b2GPI) antibodies of IgG or IgM isotype at medium to high titres in patient&rsquo;s plasma. However, several other autoantibodies targeting other coagulation cascade proteins (i.e. prothrombin) or their complex with phospholipids (i.e. phosphatidylserine/prothrombin complex), or to some domains of &beta;2GPI, have been proposed to be also relevant to APS. In fact, the value of testing for new aPL specificities in the identification of APS in thrombosis and/or pregnancy morbidity patients is currently being investigated.">
            <meta name="citation_description" content="Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including the persistent presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and/or anti-b2 glycoprotein I (anti-b2GPI) antibodies of IgG or IgM isotype at medium to high titres in patient&rsquo;s plasma. However, several other autoantibodies targeting other coagulation cascade proteins (i.e. prothrombin) or their complex with phospholipids (i.e. phosphatidylserine/prothrombin complex), or to some domains of &beta;2GPI, have been proposed to be also relevant to APS. In fact, the value of testing for new aPL specificities in the identification of APS in thrombosis and/or pregnancy morbidity patients is currently being investigated.">
            <meta name="citation_keywords" content="antiphospholipid syndrome, APS, Hughes Syndrome, ">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Maria Laura Bertolaccini">
            <meta name="citation_author_institution" content="Academic Department of Vascular Surgery, Cardiovascular Division, King&rsquo;s College London, London, UK">
            <meta name="citation_author" content="Giovanni Sanna">
            <meta name="citation_author_institution" content="Louise Coote Lupus Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK">
            <meta name="citation_publication_date" content="2016/12/22">
            <meta name="citation_volume" content="5">
            <meta name="citation_publication_number" content="2908">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.9717.1">
            <meta name="citation_firstpage" content="2908">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/5-2908/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/5-2908.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=10474 /> <input type=hidden id=articleId name=articleId value=9717 /> <input type=hidden id=xmlUrl value="/articles/5-2908/v1/xml"/> <input type=hidden id=xmlFileName value="-5-2908-v1.xml"> <input type=hidden id=article_uuid value=0527e58a-c657-444b-ad18-e25b752ca9e7 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in understanding antiphospholipid syndrome"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.9717.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.9717.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/5-2908"
  },
  "headline": "Recent advances in understanding antiphospholipid syndrome",
  "datePublished": "2016-12-22T16:54:38",
  "dateModified": "2016-12-22T16:54:38",
  "author": [
    {
      "@type": "Person",
      "name": "Maria Laura Bertolaccini"
    },    {
      "@type": "Person",
      "name": "Giovanni Sanna"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including the persistent presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and/or anti-b2 glycoprotein I (anti-b2GPI) antibodies of IgG or IgM isotype at medium to high titres in patient&rsquo;s plasma. However, several other autoantibodies targeting other coagulation cascade proteins (i.e. prothrombin) or their complex with phospholipids (i.e. phosphatidylserine/prothrombin complex), or to some domains of &beta;2GPI, have been proposed to be also relevant to APS. In fact, the value of testing for new aPL specificities in the identification of APS in thrombosis and/or pregnancy morbidity patients is currently being investigated."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/5-2908",
            "name": "Recent advances in understanding antiphospholipid syndrome"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in understanding antiphospholipid syndrome </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=10474 data-id=9717 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9717.1" data-recommended="" data-doi="10.12688/f1000research.9717.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/5-2908/v1/pdf?article_uuid=0527e58a-c657-444b-ad18-e25b752ca9e7" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-9717-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-9717-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-9717-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Bertolaccini ML and Sanna G. Recent advances in understanding antiphospholipid syndrome [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2908 (<a class=new-orange href="https://doi.org/10.12688/f1000research.9717.1" target=_blank>https://doi.org/10.12688/f1000research.9717.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-9717-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=9717 id=track-article-signin-9717 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9717?target=/articles/5-2908">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10474 /> <input name=articleId type=hidden value=9717 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in understanding antiphospholipid syndrome</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:laura.bertolaccini@kcl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Maria Laura Bertolaccini</span></a><a href="https://orcid.org/0000-0002-8623-139X" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8623-139X</div><sup>1</sup>,&nbsp;</span><span class="">Giovanni Sanna<sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:laura.bertolaccini@kcl.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Maria Laura Bertolaccini</span></a><a href="http://orcid.org/0000-0002-8623-139X" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8623-139X</div><sup>1</sup>,&nbsp;</span><span class="">Giovanni Sanna<sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 22 Dec 2016 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.9717.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Academic Department of Vascular Surgery, Cardiovascular Division, King&rsquo;s College London, London, UK<br/> <sup>2</sup> Louise Coote Lupus Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=19148-18743></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=19149-18744></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including the persistent presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and/or anti-b2 glycoprotein I (anti-b2GPI) antibodies of IgG or IgM isotype at medium to high titres in patients plasma. However, several other autoantibodies targeting other coagulation cascade proteins (i.e. prothrombin) or their complex with phospholipids (i.e. phosphatidylserine/prothrombin complex), or to some domains of 2GPI, have been proposed to be also relevant to APS. In fact, the value of testing for new aPL specificities in the identification of APS in thrombosis and/or pregnancy morbidity patients is currently being investigated. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> antiphospholipid syndrome, APS, Hughes Syndrome, </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Maria Laura Bertolaccini (<a href="mailto:laura.bertolaccini@kcl.ac.uk">laura.bertolaccini@kcl.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Maria Laura Bertolaccini </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no completing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2016 Bertolaccini ML and Sanna G. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Bertolaccini ML and Sanna G. Recent advances in understanding antiphospholipid syndrome [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2908 (<a href="https://doi.org/10.12688/f1000research.9717.1" target=_blank>https://doi.org/10.12688/f1000research.9717.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 22 Dec 2016, <b>5</b>(F1000 Faculty Rev):2908 (<a href="https://doi.org/10.12688/f1000research.9717.1" target=_blank>https://doi.org/10.12688/f1000research.9717.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 22 Dec 2016, <b>5</b>(F1000 Faculty Rev):2908 (<a href="https://doi.org/10.12688/f1000research.9717.1" target=_blank>https://doi.org/10.12688/f1000research.9717.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d25091e161>Introduction</h2><p class="" id=d25091e164>Antiphospholipid syndrome (APS), also known as Hughes Syndrome, is a systemic autoimmune disease characterized by thrombosis and/or pregnancy morbidity in the presence of persistently positive antiphospholipid antibodies<sup><a href="#ref-1">1</a></sup>. When APS was first described, it was in the presence of systemic lupus erythematosus (SLE)<sup><a href="#ref-2">2</a></sup>; however APS is now accepted to be a primary autoimmune syndrome with other accompanying characteristics, such as thrombocytopenia, seizure disorder, cognitive dysfunction, livedo reticularis, and renal vasculopathy, being frequent in the absence of the main clinical manifestations of thrombosis and pregnancy complications<sup><a href="#ref-3">3</a></sup>.</p><p class="" id=d25091e179>In 1999 definitive classification criteria for APS were published in an international consensus statement<sup><a href="#ref-4">4</a></sup> and subsequently revised in 2006<sup><a href="#ref-1">1</a></sup>. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including the persistent presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL) and/or anti-2 glycoprotein I (anti-2GPI) antibodies of IgG or IgM isotype at medium to high titres in patients plasma.</p><p class="" id=d25091e190>While it is widely accepted that the LA is the most important predictor for thrombosis<sup><a href="#ref-5">5</a><a href="#ref-7">7</a></sup>, several other autoantibodies targeting other coagulation cascade proteins (i.e. prothrombin) or their complex with phospholipid (i.e. phosphatidylserine/prothrombin complex), or to some domains of 2GPI, have been proposed to be relevant to APS<sup><a href="#ref-8">8</a></sup>. In fact, the value of testing for new aPL specificities in the identification of APS in thrombosis and/or pregnancy morbidity patients is currently being evaluated, which will be especially useful for those with recurrent negative results in present tests<sup><a href="#ref-9">9</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25091e211>New aPL specificities</h2><div class=section><a name=d25091e214 class=n-a></a><h3 class=section-title>Antibodies directed to the domain I of the 2GPI</h3><p class="" id=d25091e219>2GPI was identified as a primary target of autoantibodies in patients with APS<sup><a href="#ref-10">10</a></sup>. 2GPI is a single-chain protein containing five repeating sequences or domains. Domain V is essential for binding to anionic phospholipid membranes, whereas domain I sticks out into the extracellular space where interactions with other proteins/antibodies can take place<sup><a href="#ref-11">11</a></sup>. The development of recombinant domain specific 2GPI molecules by Iverson <i>et al</i>. in 1998<sup><a href="#ref-12">12</a></sup> steered us towards a better understanding of the specific role of the autoantibodies to each of the five 2GPI domains. Several studies have detected antibodies recognizing various domains of 2GPI<sup><a href="#ref-13">13</a></sup>. However, anti-domain I (anti-DI) antibodies were frequently found to be highly associated with clinical symptoms and therefore focused upon<sup><a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup>.</p><p class="" id=d25091e249>In their 2005 study, de Laat <i>et al</i>. reported that patients testing positive for anti-DI had a higher thrombosis risk<sup><a href="#ref-14">14</a></sup>. Antibodies recognizing epitope G40-R43 on the domain I of 2GPI caused LA and strongly correlated with thrombosis<sup><a href="#ref-14">14</a></sup>. A larger, multicentre study in 2009 looked at a large cohort of anti-2GPI positive patients, showing that those patients who were IgG anti-DI positive had a 3.5 fold increase in the risk of developing vascular thrombosis and a 2.4 fold increase in the risk of developing pregnancy morbidity when compared to those who tested negative for IgG anti-DI<sup><a href="#ref-16">16</a></sup>. Using inhibition assays, Banzato <i>et al</i>. demonstrated that high-risk patients, those bearing triple aPL positivity for aCL, LA and anti-2GPI, are those with substantially greater titre of circulating anti-DI antibodies. Those with double and single positivity showed low titre or absence of anti-DI antibodies<sup><a href="#ref-17">17</a></sup>. Conversely, when tested on 326 patients with SLE, of whom 164 had a history of thrombosis, Akhter <i>et al.</i> failed to find an association between anti-DI and these events<sup><a href="#ref-18">18</a></sup>.</p><p class="" id=d25091e282>The domain profile of anti-2GPI antibodies has also been explored in a large cohort of patients. While neither anti-DI nor anti-DIV/V antibodies were found to be associated with thrombotic events or obstetric morbidity, Andreoli <i>et al.</i> suggested that utilizing the ratio of anti-DI/anti-DIV/V could be useful as a biomarker for APS, identifying pathogenic from non-pathogenic anti-2GPI<sup><a href="#ref-15">15</a></sup>. A recent study in aCL and/or a2GPI positive patients suggests that the added finding of anti-DI positivity makes it three to five times more likely to confirm APS. Positivity for IgG or IgA (but not IgM) anti-DI increased the strength of association between aCL/a2GPI and thrombotic manifestations in APS<sup><a href="#ref-19">19</a></sup>.</p><p class="" id=d25091e296>Anti-DI antibodies have also been reported in pediatric populations. Wahezi <i>et al.</i> reported a prevalence of IgG anti-DI of 25.1% in children with SLE. However, only seven children had thrombosis, failing to ascertain a positive correlation<sup><a href="#ref-20">20</a></sup>. In a study on 64 APS patients and 57 children born to mothers with systemic autoimmune diseases, Andreoli <i>et al. s</i>howed a high prevalence of anti-DI in APS while there was a low anti-DI frequency reported in anti-2GPI positive healthy children<sup><a href="#ref-21">21</a></sup>.</p><p class="" id=d25091e314>A direct demonstration of the pathogenic effect of anti-DI antibodies has been recently shown using a human monoclonal IgG (MBB2), the infusion of which brought about fetal losses in pregnant mice and blood clots in rat mesenteric microcirculation following priming with lipopolysaccharide (LPS)<sup><a href="#ref-22">22</a></sup>. Interestingly, a variant of this antibody, lacking the CH2 domain (MBB2DCH2), was effective in preventing blood clot formation and fetal loss induced by aPL<sup><a href="#ref-22">22</a></sup>. A recombinant human domain I has also been shown to inhibit the ability of polyclonal human IgG from a patient with APS to cause thrombosis or to enhance tissue factor activity in an animal model<sup><a href="#ref-23">23</a></sup>. Using polyclonal IgG from patients with APS, anti-domain I-rich IgG significantly enhanced prothrombotic ability <i>in vivo</i> compared with anti-domain I-poor or NHS-IgG, suggesting that the ability of human APS-derived IgG to cause thrombosis in mice is concentrated in the anti-domain I-rich fraction<sup><a href="#ref-24">24</a></sup>.</p><p class="" id=d25091e336>A novel approach for developing therapy for APS has shown that tolerogenic dendritic cells specific for domain-I of the 2GPI molecule may have potential in attenuating experimental APS in a murine model, via acceleration of the differentiation of CD4<sup>+</sup> T cells to Treg cells, decreased proinflammatory cytokine production, and increased anti-inflammatory cytokine expression (IL-10 and TGF)<sup><a href="#ref-25">25</a></sup>.</p></div><div class=section><a name=d25091e347 class=n-a></a><h3 class=section-title>Antibodies to prothrombin</h3><p class="" id=d25091e352>Prothrombin (factor II) is an important antigenic target for aPL in APS. Prothrombin is a vitamin K-dependent single-chain glycoprotein of 579 amino acid residues with a molecular weight of 72-kDa. It circulates in normal plasma at a concentration of approximately 100 g/ml<sup><a href="#ref-26">26</a></sup>. Antibodies directed to human prothrombin (aPT) and the complex of phosphatidylserine/prothrombin (aPS/PT) are detected by ELISA and have been strongly associated with APS<sup><a href="#ref-27">27</a></sup>. While the presence of these antibodies have been shown to correlate in some cases<sup><a href="#ref-28">28</a></sup>, it seems that aPT and aPS/PT belong to different populations of autoantibodies<sup><a href="#ref-9">9</a></sup>.</p><p class="" id=d25091e371>A systematic review of the literature including 6000 patients and 1400 controls has been recently reported<sup><a href="#ref-27">27</a></sup>. aPS/PT was shown to represent a stronger risk factor for thrombosis, both arterial and/or venous, than aPT, with an odds ratio (OR) of 5<sup><a href="#ref-27">27</a></sup>. Data from our group and others suggest that the risk of thrombosis progressively increases with the increase in number of positive aPL tests<sup><a href="#ref-29">29</a><a href="#ref-32">32</a></sup>. Recently, we showed that testing positive for all three antibodiesLA, anti-2GPI and aPS/PT was the best diagnostic indication of APS<sup><a href="#ref-33">33</a></sup>. In addition, when compared with double or single positivity, this triple combination showed a stronger correlation with clinical events (thrombosis and/or pregnancy loss).</p><p class="" id=d25091e393>The mechanisms underlying the procoagulant properties of antibodies to prothrombin are not known; currently two are being postulated: a) indirect; through humoral regulators of coagulation (i.e. prothrombin) or b) direct; engaging/activating cell receptors. An isolated report suggests that polyclonal antibodies from patients with antiprothrombin antibodies might act on a target molecule expressed at the endothelial cell surface<sup><a href="#ref-34">34</a></sup>, although this is as yet uncharacterised. Tissue factor production induced by aPS/PT in procoagulant cells is reported to occur predominantly via activation of the p38 mitogen-activated protein kinase (MAPK) pathway<sup><a href="#ref-35">35</a></sup>, similar to the mechanisms implicated in anti-2GPI-induced cell activation<sup><a href="#ref-36">36</a></sup>. In the mouse, active immunisation with prothrombin is associated with increased thrombosis, supporting a role for antibodies to prothrombin in thrombus formation<sup><a href="#ref-37">37</a></sup>. In addition, mice treated with IS6 (a mouse monoclonal antiprothrombin antibody) show thrombi that are larger and persist longer than in mice injected with control antibody<sup><a href="#ref-34">34</a></sup>.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25091e420>Pathogenic mechanisms of aPL</h2><p class="" id=d25091e423>Despite our incomplete understanding of APS pathogenesis, the major facets have been defined in recent years. Thrombosis, a key feature of the disease, can be the result of various mechanisms, including endothelial cells, monocytes, platelets, coagulation, and complement pathways, as well as blocking of the fibrinolytic and anticoagulation pathways. The conventional understanding is that aPL antibodies bind to receptors on target cells, causing their activation and leading to thrombosis in large vessels<sup><a href="#ref-38">38</a></sup>. A number of processes have been implicated as effectors of a prothrombotic state in APS. These include: the generation of tissue factor<sup><a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>; complement activation<sup><a href="#ref-41">41</a><a href="#ref-43">43</a></sup>; activated platelet-enhanced endothelial activation<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>; monocyte protease receptor activation<sup><a href="#ref-46">46</a></sup>; and the generation of DNA nets by neutrophils<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>.</p><p class="" id=d25091e463>aPL have been proposed to bind to cellular membranes via various different receptors, including annexin A2<sup><a href="#ref-47">47</a><a href="#ref-50">50</a></sup>, apolipoprotein E receptor 2 (ApoER2)<sup><a href="#ref-51">51</a><a href="#ref-53">53</a></sup>, low-density-lipoprotein receptor (LDL-R)<sup><a href="#ref-54">54</a></sup>, megalin<sup><a href="#ref-55">55</a></sup>, Toll-like receptors 2<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup> and 4<sup><a href="#ref-50">50</a>,<a href="#ref-58">58</a></sup>, and the very-LDL-R and P-selectin glycoprotein (GP) ligand-1. It has also been shown that 2GPI is able to directly bind to the platelet adhesive receptor GPIb<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup> and the platelet factor4 (PF4)<sup><a href="#ref-61">61</a></sup>.</p><p class="" id=d25091e514>Antibody binding to aPL receptors on target cells activates intracellular mediators like nuclear factor kappa B (NF-B) and p38MAPK<sup><a href="#ref-62">62</a></sup>.</p><p class="" id=d25091e521>aPL have also been shown to activate the phosphatidylinositol 3-kinase (PI3K)AKT pathway. Activation of this signaling cascade engages the mammalian target of rapamycin (mTOR), a kinase modulating cellular growth, proliferation and survival<sup><a href="#ref-63">63</a></sup>. Polyclonal aPL from APS patients induced a marked increase in S6RP and AKT (Ser473) phosphorylation, two of the components of the mTOR pathway, mediating intimal hyperplasia and chronic vasculopathy often seen in APS<sup><a href="#ref-63">63</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25091e535>aPL and the Coagulation System</h2><p class="" id=d25091e538>aPL have been reported to inhibit the anticoagulant properties of activated protein C (APC)<sup><a href="#ref-64">64</a>,<a href="#ref-65">65</a></sup>, impair fibrinolysis<sup><a href="#ref-66">66</a><a href="#ref-69">69</a></sup>, reduce tissue factor pathway inhibitor (TFPI) activity<sup><a href="#ref-70">70</a>,<a href="#ref-71">71</a></sup> and 2GPI-thrombin interaction<sup><a href="#ref-72">72</a>,<a href="#ref-73">73</a></sup>, and disrupt the annexin A5 anticoagulant shield<sup><a href="#ref-74">74</a><a href="#ref-77">77</a></sup>. The binding of aPL to 2GPI diminishes 2GPI complement regulatory function with the consequent impaired clearance of apoptotic cells<sup><a href="#ref-78">78</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25091e584>aPL as risk factors for thrombosis: Scoring Systems in APS</h2><p class="" id=d25091e587>One of the unexplained matters in APS is why some patients develop thrombotic events while others present with morbidity in pregnancy. While a minority of patients may also develop a life-threatening catastrophic form of APS with multiple organ involvement and a high death rate, others never develop any aPL-related manifestation.</p><p class="" id=d25091e590>In this context, assessing the patient risk of developing an aPL-related manifestation is crucially important for physicians. Three score systems have been formulated to quantify the risk of thrombosis/obstetric events in APS<sup><a href="#ref-31">31</a>,<a href="#ref-79">79</a>,<a href="#ref-80">80</a></sup>.</p><p class="" id=d25091e603>In 2011, a risk model for APS diagnosis was developed based on patient positivity for aPL along with their titre and the results obtained for LA investigation<sup><a href="#ref-31">31</a></sup>. Probability estimates for diagnosis of APS were obtained using logistic regression equations and the authors demonstrated that multiple aPL positivity, primarily the triple association of LA, aCL and anti-2GPI, increased the risk of APS. LA was shown to be the strongest aPL associated with the diagnosis of APS.</p><p class="" id=d25091e610>In an attempt to quantify the risk based on the aPL profile, Otomo <i>et al.</i><sup><a href="#ref-79">79</a></sup> designed the antiphospholipid score or aPL-S. The aPL profiles were analyzed using six ELISAs (IgG/IgM aCL, IgG/IgM anti-2GPI, and IgG/IgM aPS/PT) and five clotting assays for LA. An algorithm generated this score, with each assay being assigned different points weighted on the relative risk of having a clinical manifestation of APS. The prevalence of APS manifestations increased with the increasing aPL-S, suggesting that the aPL-S could serve as a marker of the probability of APS and a valuable tool for predicting thrombosis. An independent validation in a separate cohort of 211 consecutive SLE patients confirmed the aPL-S correlation with a history of thrombosis or pregnancy loss<sup><a href="#ref-81">81</a></sup>.</p><p class="" id=d25091e624>Our newly developed alternative score for APS diagnosis (Global APS score or GAPSS) is based on independent thrombosis and pregnancy loss risk factors<sup><a href="#ref-80">80</a></sup>. This score accounts for established cardiovascular risk factors and the autoimmune antibodies profile in addition to the aPL profile (criteria aPL<sup><a href="#ref-1">1</a></sup> and non-criteria aPL<sup><a href="#ref-82">82</a></sup>). We developed and validated the score system in a SLE cohort. The analysis included data on clinical manifestations, conventional cardiovascular risk factors, aPL and autoimmune profile (including ANA, ENA and anti-dsDNA, among others). Weighted points proportional to the -regression-coefficient values were assigned to each independent risk factor identified by multivariate analysis. Validation was performed in a second cohort of patients showing statistically significant higher values of GAPSS in those with a clinical history of thrombosis and/or pregnancy loss when compared to those without events.</p><p class="" id=d25091e639>When applied in a prospectively followed-up cohort of SLE patients, an increase in the GAPSS during this follow up was found to be associated with a 12-fold increase in the risk of vascular events. In detail, an increase of more than 3 GAPSS points seemed to have the best risk accuracy for vascular events with a hazard ratio of 48<sup><a href="#ref-83">83</a></sup>. </p><p class="" id=d25091e646>This score was also applied to a cohort of primary APS, higher values of GAPSS were seen in APS patients who experienced thrombosis when compared to those with previous pregnancy loss alone. In addition, GAPSS was able to discriminate patients who experienced recurrent thrombotic events from those without recurrences<sup><a href="#ref-84">84</a></sup>.</p><p class="" id=d25091e653>This score was independently validated by two groups. Zuily <i>et al.</i> <sup><a href="#ref-85">85</a></sup> evaluated the validity of the GAPPS to predict thrombosis in a prospective multicentre cohort study. GAPSS values were significantly higher in patients who experienced a thrombotic event when compared to those without with a reported GAPSS above 16 as a significant predictor of thrombosis in this population. Oku <i>et al</i>.<sup><a href="#ref-86">86</a></sup> confirmed that GAPSS can be successfully used to quantify risk in an independent cohort of patients with autoimmune diseases. GAPSS correlated with a history of APS symptoms, particularly with thrombosis, implying it can be used as an appropriate quantitative marker for APS.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25091e674>Classification vs. diagnostic criteria</h2><p class="" id=d25091e677>As stated above, in 1999, definitive classification criteria for APS were published in an international consensus statement<sup><a href="#ref-4">4</a></sup> and a subsequent revision was made in 2006<sup><a href="#ref-1">1</a></sup>. A patient with APS must meet at least one of two clinical criteria (vascular thrombosis or complications of pregnancy) and at least one of two laboratory criteria including the persistent presence of lupus anticoagulant (LA), anticardiolipin antibodies (aCL) and/or anti-2GPI antibodies of IgG or IgM isotype at medium to high titres in patients plasma.</p><p class="" id=d25091e688>These classification criteria are aimed at identifying well defined, relatively homogeneous group of patients, all sharing key features of the condition, as they do not reflect the different features of the disease, as diagnostic criteria should<sup><a href="#ref-87">87</a></sup>. To date, there are no diagnostic criteria available for APS and, therefore, even with a lack of essential or key features, clinicians should be encouraged to consider the diagnosis in the presence of minor features, providing other causes have been ruled out.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25091e698>aPL carriers</h2><p class="" id=d25091e701>Overall data from available studies suggest that asymptomatic aPL carriers bear a 02.8% annual risk of developing a thrombotic event<sup><a href="#ref-88">88</a></sup>. While the presence of aPL is necessary but not sufficient to provoke a thrombotic event, the second hit hypothesis suggests that an additional trigger is needed to initiate a vascular event in aPL carriers.</p><p class="" id=d25091e708>An early study from 1998<sup><a href="#ref-89">89</a></sup> evaluated the prevalence of thrombosis in aCL positive patients with SLE. The authors reported that 52% of aCL carriers developed a thrombotic event during the 10-year follow up, opening the question on the importance of these antibodies as risk factors for thrombosis. From then, few other studies have estimated the incidence of thrombosis in asymptomatic carriers with aPL. A total of 178 asymptomatic aPL carriers without underlying autoimmune diseases underwent a 3-year prospective observational cohort study and no thrombotic events were reported during follow up<sup><a href="#ref-90">90</a></sup>. The APLASA study, a randomized, double-blind, placebo-controlled trial investigating the efficacy of low-dose aspirin (LDA) as primary prevention of thrombotic events showed a low incidence of thrombosis in aPL carriers, events occurring in all but one of the cases, in the presence of concomitant thrombosis risk factors and/or systemic autoimmune disease at the time of thrombosis<sup><a href="#ref-91">91</a></sup>. A prospective study identified hypertension and LA as independent risk factors for a first thrombotic event in asymptomatic aPL carriers<sup><a href="#ref-92">92</a></sup>.</p><p class="" id=d25091e727>A recent study evaluating the efficacy and safety of LDA vs. LDA plus low-intensity warfarin in the primary thrombosis prevention of aPL-positive patients with SLE and/or obstetric morbidity reported an incidence of 1.8 events/100 person-years in the randomized group<sup><a href="#ref-93">93</a></sup>. Interestingly, this incidence was increased to 4.9 events/100 person-years in the observational arm with hypertension being the most frequent additional risk factor.</p><p class="" id=d25091e734>Evidence shows that patients with more than one positive test, and particularly those with all three positive aPL tests (referred to as triple positive), are those with a strong association with clinical events<sup><a href="#ref-29">29</a>,<a href="#ref-30">30</a></sup>. Therefore, aPL carriers should be risk-stratified according to the aPL status, the presence of other cardiovascular risk factors that should be closely monitored and controlled whenever possible, and the concomitance of other systemic autoimmune diseases.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d25091e747>Conclusions</h2><p class="" id=d25091e750>Studies are underway to establish the value of testing for new aPL specificities in the identification of APS in patients with thrombosis and/or pregnancy morbidity, particularly in those for whom repeated testing produces negative results with currently available methods. While their clinical importance and mechanisms of action are far from being fully explored, available data suggest that the presence of these other aPL, particularly anti-DI and aPS/PT antibodies, are useful for risk stratification.</p><p class="" id=d25091e753>Ongoing research focuses on cell receptors and intracellular signaling pathways involved in the cell activation mediated by aPL. The clarification of these mechanisms is crucial to a better understanding of pathogenesis of APS. Although some controversial data still exist in regards to new specificities, most of the available reports support the association between aPS/PT, and to a lesser extent anti-DI, and the clinical manifestations of APS. Additional studies to conclusively define the relevance and prognosis impact of testing for these antibodies in the daily routine clinical practice are still required.</p><p class="" id=d25091e756>When assessing risk, the use of GAPSS may provide valuable information regarding thrombosis or pregnancy loss risk, switching from the concept of aPL as simply diagnostic antibodies to aPL as relevant risk factors for clinical events.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d25091e1 class=n-a></a><h2 class=main-title id=d25409>Competing interests</h2><p class=metadata-entry><a name=d25091e96 class=n-a></a><p id=d25091e98> The authors declare that they have no completing interests.</p></p></div><div class=back-section><a name=d25091e1 class=n-a></a><h2 class=main-title id=d25411>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d25091e763 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d25702>References</h2><div class="section ref-list"><a name=d25091e763 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d25091e770 class=n-a></a>Miyakis S, Lockshin MD, Atsumi T, <i> et al.</i>: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). <i>J Thromb Haemost.</i> 2006; <b>4</b>(2): 295306. <a target=xrefwindow id=d25091e781 href="http://www.ncbi.nlm.nih.gov/pubmed/16420554">PubMed Abstract </a> | <a target=xrefwindow id=d25091e784 href="http://dx.doi.org/10.1111/j.1538-7836.2006.01753.x">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d25091e793 class=n-a></a>Hughes GR: Hughes' syndrome: the antiphospholipid syndrome. A historical view. <i>Lupus.</i> 1998; <b>7</b>(Suppl 2): S14. <a target=xrefwindow id=d25091e801 href="http://www.ncbi.nlm.nih.gov/pubmed/9814662">PubMed Abstract </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727105880"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e810 class=n-a></a>Abreu MM, Danowski A, Wahl DG, <i> et al.</i>: The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features. <i>Autoimmun Rev.</i> 2015; <b>14</b>(5): 40114. <a target=xrefwindow id=d25091e821 href="http://www.ncbi.nlm.nih.gov/pubmed/25641203">PubMed Abstract </a> | <a target=xrefwindow id=d25091e824 href="http://dx.doi.org/10.1016/j.autrev.2015.01.002">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727105880">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d25091e837 class=n-a></a>Wilson WA, Gharavi AE, Koike T, <i> et al.</i>: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. <i>Arthritis Rheum.</i> 1999; <b>42</b>(7): 130911. <a target=xrefwindow id=d25091e848 href="http://www.ncbi.nlm.nih.gov/pubmed/10403256">PubMed Abstract </a> | <a target="xrefwindow" id="d25091e851" href="http://dx.doi.org/10.1002/1529-0131(199907)42:7<1309::AID-ANR1&gt;3.0.CO;2-F">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d25091e860 class=n-a></a>Galli M, Luciani D, Bertolini G, <i> et al.</i>: Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. <i>Blood.</i> 2003; <b>101</b>(5): 182732. <a target=xrefwindow id=d25091e871 href="http://www.ncbi.nlm.nih.gov/pubmed/12393574">PubMed Abstract </a> | <a target=xrefwindow id=d25091e874 href="http://dx.doi.org/10.1182/blood-2002-02-0441">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d25091e884 class=n-a></a>Horbach DA, van Oort E, Donders RC, <i> et al.</i>: Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. <i>Thromb Haemost.</i> 1996; <b>76</b>(6): 91624. <a target=xrefwindow id=d25091e895 href="http://www.ncbi.nlm.nih.gov/pubmed/8972011">PubMed Abstract </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d25091e904 class=n-a></a>Wahl DG, Guillemin F, de Maistre E, <i> et al.</i>: Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis. <i>Lupus.</i> 1997; <b>6</b>(5): 46773. <a target=xrefwindow id=d25091e915 href="http://www.ncbi.nlm.nih.gov/pubmed/9229367">PubMed Abstract </a> | <a target=xrefwindow id=d25091e918 href="http://dx.doi.org/10.1177/096120339700600510">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d25091e927 class=n-a></a>Bertolaccini ML, Amengual O, Andreoli L, <i> et al.</i>: 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. <i>Autoimmun Rev.</i> 2014; <b>13</b>(9): 91730. <a target=xrefwindow id=d25091e938 href="http://www.ncbi.nlm.nih.gov/pubmed/24824074">PubMed Abstract </a> | <a target=xrefwindow id=d25091e941 href="http://dx.doi.org/10.1016/j.autrev.2014.05.001">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d25091e950 class=n-a></a>Bertolaccini ML, Gomez S, Pareja JF, <i> et al.</i>: Antiphospholipid antibody tests: spreading the net. <i>Ann Rheum Dis.</i> 2005; <b>64</b>(11): 163943. <a target=xrefwindow id=d25091e961 href="http://www.ncbi.nlm.nih.gov/pubmed/15817655">PubMed Abstract </a> | <a target=xrefwindow id=d25091e964 href="http://dx.doi.org/10.1136/ard.2005.035824">Publisher Full Text </a> | <a target=xrefwindow id=d25091e968 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1755259">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d25091e977 class=n-a></a>McNeil HP, Simpson RJ, Chesterman CN, <i> et al.</i>: Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). <i>Proc Natl Acad Sci U S A.</i> 1990; <b>87</b>(11): 41204. <a target=xrefwindow id=d25091e988 href="http://www.ncbi.nlm.nih.gov/pubmed/2349221">PubMed Abstract </a> | <a target=xrefwindow id=d25091e991 href="http://dx.doi.org/10.1073/pnas.87.11.4120">Publisher Full Text </a> | <a target=xrefwindow id=d25091e995 href="http://www.ncbi.nlm.nih.gov/pmc/articles/54059">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d25091e1004 class=n-a></a>Miyakis S, Giannakopoulos B, Krilis SA: Beta 2 glycoprotein I--function in health and disease. <i>Thromb Res.</i> 2004; <b>114</b>(5-6): 33546. <a target=xrefwindow id=d25091e1012 href="http://www.ncbi.nlm.nih.gov/pubmed/15507263">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1015 href="http://dx.doi.org/10.1016/j.thromres.2004.07.017">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d25091e1025 class=n-a></a>Iverson GM, Victoria EJ, Marquis DM: Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. <i>Proc Natl Acad Sci U S A.</i> 1998; <b>95</b>(26): 155426. <a target=xrefwindow id=d25091e1033 href="http://www.ncbi.nlm.nih.gov/pubmed/9861005">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1036 href="http://dx.doi.org/10.1073/pnas.95.26.15542">Publisher Full Text </a> | <a target=xrefwindow id=d25091e1039 href="http://www.ncbi.nlm.nih.gov/pmc/articles/28079">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d25091e1048 class=n-a></a>de Laat B, Mertens K, de Groot PG: Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism. <i>Nat Clin Pract Rheumatol.</i> 2008; <b>4</b>(4): 1929. <a target=xrefwindow id=d25091e1056 href="http://www.ncbi.nlm.nih.gov/pubmed/18285765">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1059 href="http://dx.doi.org/10.1038/ncprheum0740">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d25091e1068 class=n-a></a>de Laat B, Derksen RH, Urbanus RT, <i> et al.</i>: IgG antibodies that recognize epitope Gly40-Arg43 in domain I of <sub>2</sub>-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. <i>Blood.</i> 2005; <b>105</b>(4): 15405. <a target=xrefwindow id=d25091e1082 href="http://www.ncbi.nlm.nih.gov/pubmed/15507529">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1086 href="http://dx.doi.org/10.1182/blood-2004-09-3387">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725465843"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1095 class=n-a></a>Andreoli L, Chighizola CB, Nalli C, <i> et al.</i>: Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against <sub>2</sub> -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(8): 2196204. <a target=xrefwindow id=d25091e1109 href="http://www.ncbi.nlm.nih.gov/pubmed/25939498">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1113 href="http://dx.doi.org/10.1002/art.39187">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725465843">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d25091e1126 class=n-a></a>de Laat B, Pengo V, Pabinger I, <i> et al.</i>: The association between circulating antibodies against domain I of <sub>2</sub>-glycoprotein I and thrombosis: an international multicenter study. <i>J Thromb Haemost.</i> 2009; <b>7</b>(11): 176773. <a target=xrefwindow id=d25091e1140 href="http://www.ncbi.nlm.nih.gov/pubmed/19694946">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1144 href="http://dx.doi.org/10.1111/j.1538-7836.2009.03588.x">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d25091e1153 class=n-a></a>Banzato A, Pozzi N, Frasson R, <i> et al.</i>: Antibodies to Domain I of <sub>2</sub>Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS). <i>Thromb Res.</i> 2011; <b>128</b>(6): 5836. <a target=xrefwindow id=d25091e1167 href="http://www.ncbi.nlm.nih.gov/pubmed/21620443">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1171 href="http://dx.doi.org/10.1016/j.thromres.2011.04.021">Publisher Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/724375869"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1181 class=n-a></a>Akhter E, Shums Z, Norman GL, <i> et al.</i>: Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus. <i>J Rheumatol.</i> 2013; <b>40</b>(3): 2826. <a target=xrefwindow id=d25091e1192 href="http://www.ncbi.nlm.nih.gov/pubmed/23378459">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1195 href="http://dx.doi.org/10.3899/jrheum.120084">Publisher Full Text </a> | <a target=xrefwindow id=d25091e1199 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3605900">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/724375869">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/726394658"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1212 class=n-a></a>Pericleous C, Ferreira I, Borghi O, <i> et al.</i>: Measuring IgA Anti-2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome. <i>PLoS One.</i> 2016; <b>11</b>(6): e0156407. <a target=xrefwindow id=d25091e1223 href="http://www.ncbi.nlm.nih.gov/pubmed/27253369">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1226 href="http://dx.doi.org/10.1371/journal.pone.0156407">Publisher Full Text </a> | <a target=xrefwindow id=d25091e1230 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4890741">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/726394658">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727105885"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1243 class=n-a></a>Wahezi DM, Ilowite NT, Wu XX, <i> et al.</i>: Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of 2-glycoprotein I. <i>Lupus.</i> 2013; <b>22</b>(7): 70211. <a target=xrefwindow id=d25091e1254 href="http://www.ncbi.nlm.nih.gov/pubmed/23690366">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1257 href="http://dx.doi.org/10.1177/0961203313490241">Publisher Full Text </a> | <a target=xrefwindow id=d25091e1261 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4138827">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727105885">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d25091e1274 class=n-a></a>Andreoli L, Nalli C, Motta M, <i> et al.</i>: Anti-<sub>2</sub>-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? <i>Ann Rheum Dis.</i> 2011; <b>70</b>(2): 3803. <a target=xrefwindow id=d25091e1288 href="http://www.ncbi.nlm.nih.gov/pubmed/20971718">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1292 href="http://dx.doi.org/10.1136/ard.2010.137281">Publisher Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718314378"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1301 class=n-a></a>Agostinis C, Durigutto P, Sblattero D, <i> et al.</i>: A non-complement-fixing antibody to 2 glycoprotein I as a novel therapy for antiphospholipid syndrome. <i>Blood.</i> 2014; <b>123</b>(22): 347887. <a target=xrefwindow id=d25091e1312 href="http://www.ncbi.nlm.nih.gov/pubmed/24642748">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1315 href="http://dx.doi.org/10.1182/blood-2013-11-537704">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718314378">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d25091e1328 class=n-a></a>Ioannou Y, Romay-Penabad Z, Pericleous C, <i> et al.</i>: <i>In vivo</i> inhibition of antiphospholipid antibody-induced pathogenicity utilizing the antigenic target peptide domain I of <sub>2</sub>-glycoprotein I: proof of concept. <i>J Thromb Haemost.</i> 2009; <b>7</b>(5): 83342. <a target=xrefwindow id=d25091e1346 href="http://www.ncbi.nlm.nih.gov/pubmed/19220729">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1349 href="http://dx.doi.org/10.1111/j.1538-7836.2009.03316.x">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/719128881"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1359 class=n-a></a>Pericleous C, Ruiz-Limn P, Romay-Penabad Z, <i> et al.</i>: Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of <sub>2</sub>-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis. <i>Rheumatology (Oxford).</i> 2015; <b>54</b>(4): 7227. <a target=xrefwindow id=d25091e1373 href="http://www.ncbi.nlm.nih.gov/pubmed/25273993">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1377 href="http://dx.doi.org/10.1093/rheumatology/keu360">Publisher Full Text </a> | <a target=xrefwindow id=d25091e1380 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4372675">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/719128881">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718471368"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1393 class=n-a></a>Zandman-Goddard G, Pierangeli SS, Gertel S, <i> et al.</i>: Tolerogenic dendritic cells specific for <sub>2</sub>-glycoprotein-I Domain-I, attenuate experimental antiphospholipid syndrome. <i>J Autoimmun.</i> 2014; <b>54</b>: 7280. <a target=xrefwindow id=d25091e1407 href="http://www.ncbi.nlm.nih.gov/pubmed/24972993">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1411 href="http://dx.doi.org/10.1016/j.jaut.2014.06.001">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718471368">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d25091e1424 class=n-a></a>Chow BK, Ting V, Tufaro F, <i> et al.</i>: Characterization of a novel liver-specific enhancer in the human prothrombin gene. <i>J Biol Chem.</i> 1991; <b>266</b>(28): 1892733. <a target=xrefwindow id=d25091e1435 href="http://www.ncbi.nlm.nih.gov/pubmed/1918008">PubMed Abstract </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d25091e1444 class=n-a></a>Sciascia S, Sanna G, Murru V, <i> et al.</i>: Anti-prothrombin (aPT) and anti-phosphatidylserine/prothrombin (aPS/PT) antibodies and the risk of thrombosis in the antiphospholipid syndrome. A systematic review. <i>Thromb Haemost.</i> 2014; <b>111</b>(2): 35464. <a target=xrefwindow id=d25091e1455 href="http://www.ncbi.nlm.nih.gov/pubmed/24172938">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1458 href="http://dx.doi.org/10.1160/TH13-06-0509">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d25091e1467 class=n-a></a>Bertolaccini ML, Atsumi T, Koike T, <i> et al.</i>: Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance in systemic lupus erythematosus. <i>Thromb Haemost.</i> 2005; <b>93</b>(2): 28997. <a target=xrefwindow id=d25091e1478 href="http://www.ncbi.nlm.nih.gov/pubmed/15711745">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1481 href="http://dx.doi.org/10.1160/TH04-06-0382">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d25091e1490 class=n-a></a>Pengo V, Ruffatti A, Legnani C, <i> et al.</i>: Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. <i>J Thromb Haemost.</i> 2010; <b>8</b>(2): 23742. <a target=xrefwindow id=d25091e1501 href="http://www.ncbi.nlm.nih.gov/pubmed/19874470">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1504 href="http://dx.doi.org/10.1111/j.1538-7836.2009.03674.x">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d25091e1514 class=n-a></a>Pengo V, Biasiolo A, Pegoraro C, <i> et al.</i>: Antibody profiles for the diagnosis of antiphospholipid syndrome. <i>Thromb Haemost.</i> 2005; <b>93</b>(6): 114752. <a target=xrefwindow id=d25091e1525 href="http://www.ncbi.nlm.nih.gov/pubmed/15968401">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1528 href="http://dx.doi.org/10.1160/TH04-12-0839">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d25091e1537 class=n-a></a>Sciascia S, Cosseddu D, Montaruli B, <i> et al.</i>: Risk Scale for the diagnosis of antiphospholipid syndrome. <i>Ann Rheum Dis.</i> 2011; <b>70</b>(8): 15178. <a target=xrefwindow id=d25091e1548 href="http://www.ncbi.nlm.nih.gov/pubmed/21402561">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1551 href="http://dx.doi.org/10.1136/ard.2010.145177">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d25091e1560 class=n-a></a>Pengo V, Ruffatti A, Legnani C, <i> et al.</i>: Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study. <i>Blood.</i> 2011; <b>118</b>(17): 47148. <a target=xrefwindow id=d25091e1571 href="http://www.ncbi.nlm.nih.gov/pubmed/21765019">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1574 href="http://dx.doi.org/10.1182/blood-2011-03-340232">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d25091e1583 class=n-a></a>Sciascia S, Murru V, Sanna G, <i> et al.</i>: Clinical accuracy for diagnosis of antiphospholipid syndrome in systemic lupus erythematosus: evaluation of 23 possible combinations of antiphospholipid antibody specificities. <i>J Thromb Haemost.</i> 2012; <b>10</b>(12): 25128. <a target=xrefwindow id=d25091e1594 href="http://www.ncbi.nlm.nih.gov/pubmed/23025466">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1597 href="http://dx.doi.org/10.1111/jth.12014">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d25091e1606 class=n-a></a>Vega-Ostertag M, Liu X, Kwan-Ki H, <i> et al.</i>: A human monoclonal antiprothrombin antibody is thrombogenic <i>in vivo</i> and upregulates expression of tissue factor and E-selectin on endothelial cells. <i>Br J Haematol.</i> 2006; <b>135</b>(2): 2149. <a target=xrefwindow id=d25091e1620 href="http://www.ncbi.nlm.nih.gov/pubmed/16965389">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1624 href="http://dx.doi.org/10.1111/j.1365-2141.2006.06283.x">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718064818"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1633 class=n-a></a>Oku K, Amengual O, Zigon P, <i> et al.</i>: Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody. <i>Rheumatology (Oxford).</i> 2013; <b>52</b>(10): 177584. <a target=xrefwindow id=d25091e1644 href="http://www.ncbi.nlm.nih.gov/pubmed/23878313">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1647 href="http://dx.doi.org/10.1093/rheumatology/ket234">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718064818">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d25091e1661 class=n-a></a>Lpez-Pedrera C, Buenda P, Cuadrado MJ, <i> et al.</i>: Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. <i>Arthritis Rheum.</i> 2006; <b>54</b>(1): 30111. <a target=xrefwindow id=d25091e1672 href="http://www.ncbi.nlm.nih.gov/pubmed/16385547">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1675 href="http://dx.doi.org/10.1002/art.21549">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d25091e1684 class=n-a></a>Haj-Yahia S, Sherer Y, <i> et al.</i>: Anti-prothrombin antibodies cause thrombosis in a novel qualitative <i>ex-vivo</i> animal model. <i>Lupus.</i> 2003; <b>12</b>(5): 3649. <a target=xrefwindow id=d25091e1698 href="http://www.ncbi.nlm.nih.gov/pubmed/12765299">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1702 href="http://dx.doi.org/10.1191/0961203303lu370oa">Publisher Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d25091e1711 class=n-a></a>Du VX, Kelchtermans H, de Groot PG, <i> et al.</i>: From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome. <i>Thromb Res.</i> 2013; <b>132</b>(3): 31926. <a target=xrefwindow id=d25091e1722 href="http://www.ncbi.nlm.nih.gov/pubmed/23958468">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1725 href="http://dx.doi.org/10.1016/j.thromres.2013.07.023">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d25091e1734 class=n-a></a>Cuadrado MJ, Lpez-Pedrera C, Khamashta MA, <i> et al.</i>: Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. <i>Arthritis Rheum.</i> 1997; <b>40</b>(5): 83441. <a target=xrefwindow id=d25091e1745 href="http://www.ncbi.nlm.nih.gov/pubmed/9153543">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1748 href="http://dx.doi.org/10.1002/art.1780400509">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d25091e1757 class=n-a></a>Amengual O, Atsumi T, Khamashta MA, <i> et al.</i>: The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. <i>Thromb Haemost.</i> 1998; <b>79</b>(2): 27681. <a target=xrefwindow id=d25091e1768 href="http://www.ncbi.nlm.nih.gov/pubmed/9493575">PubMed Abstract </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d25091e1777 class=n-a></a>Pierangeli SS, Girardi G, Vega-Ostertag M, <i> et al.</i>: Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. <i>Arthritis Rheum.</i> 2005; <b>52</b>(7): 21204. <a target=xrefwindow id=d25091e1788 href="http://www.ncbi.nlm.nih.gov/pubmed/15986360">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1791 href="http://dx.doi.org/10.1002/art.21157">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d25091e1801 class=n-a></a>Oku K, Atsumi T, Bohgaki M, <i> et al.</i>: Complement activation in patients with primary antiphospholipid syndrome. <i>Ann Rheum Dis.</i> 2009; <b>68</b>(6): 10305. <a target=xrefwindow id=d25091e1812 href="http://www.ncbi.nlm.nih.gov/pubmed/18625630">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1815 href="http://dx.doi.org/10.1136/ard.2008.090670">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d25091e1824 class=n-a></a>Breen KA, Seed P, Parmar K, <i> et al.</i>: Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome. <i>Thromb Haemost.</i> 2012; <b>107</b>(3): 4239. <a target=xrefwindow id=d25091e1835 href="http://www.ncbi.nlm.nih.gov/pubmed/22234447">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1838 href="http://dx.doi.org/10.1160/TH11-08-0554">Publisher Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/718387182"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1847 class=n-a></a>Proulle V, Furie RA, Merrill-Skoloff G, <i> et al.</i>: Platelets are required for enhanced activation of the endothelium and fibrinogen in a mouse thrombosis model of APS. <i>Blood.</i> 2014; <b>124</b>(4): 61122. <a target=xrefwindow id=d25091e1858 href="http://www.ncbi.nlm.nih.gov/pubmed/24825863">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1861 href="http://dx.doi.org/10.1182/blood-2014-02-554980">Publisher Full Text </a> | <a target=xrefwindow id=d25091e1865 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4110663">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/718387182">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725580130"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e1878 class=n-a></a>Yalavarthi S, Gould TJ, Rao AN, <i> et al.</i>: Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome. <i>Arthritis Rheumatol.</i> 2015; <b>67</b>(11): 29903003. <a target=xrefwindow id=d25091e1889 href="http://www.ncbi.nlm.nih.gov/pubmed/26097119">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1892 href="http://dx.doi.org/10.1002/art.39247">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725580130">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d25091e1905 class=n-a></a>Lpez-Pedrera C, Aguirre MA, Buenda P, <i> et al.</i>: Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome. <i>Arthritis Rheum.</i> 2010; <b>62</b>(3): 86977. <a target=xrefwindow id=d25091e1916 href="http://www.ncbi.nlm.nih.gov/pubmed/20131237">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1919 href="http://dx.doi.org/10.1002/art.27299">Publisher Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d25091e1928 class=n-a></a>Ma K, Simantov R, Zhang JC, <i> et al.</i>: High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. <i>J Biol Chem.</i> 2000; <b>275</b>(20): 155418. <a target=xrefwindow id=d25091e1939 href="http://www.ncbi.nlm.nih.gov/pubmed/10809787">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1942 href="http://dx.doi.org/10.1074/jbc.275.20.15541">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d25091e1952 class=n-a></a>Zhang J, McCrae KR: Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. <i>Blood.</i> 2005; <b>105</b>(5): 19649. <a target=xrefwindow id=d25091e1960 href="http://www.ncbi.nlm.nih.gov/pubmed/15471954">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1963 href="http://dx.doi.org/10.1182/blood-2004-05-1708">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d25091e1972 class=n-a></a>Romay-Penabad Z, Montiel-Manzano MG, Shilagard T, <i> et al.</i>: Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects <i>in vitro</i> and <i>in vivo</i>. <i>Blood.</i> 2009; <b>114</b>(14): 307483. <a target=xrefwindow id=d25091e1990 href="http://www.ncbi.nlm.nih.gov/pubmed/19628708">PubMed Abstract </a> | <a target=xrefwindow id=d25091e1993 href="http://dx.doi.org/10.1182/blood-2008-11-188698">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d25091e2002 class=n-a></a>Sorice M, Longo A, Capozzi A, <i> et al.</i>: Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. <i>Arthritis Rheum.</i> 2007; <b>56</b>(8): 268797. <a target=xrefwindow id=d25091e2013 href="http://www.ncbi.nlm.nih.gov/pubmed/17665396">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2016 href="http://dx.doi.org/10.1002/art.22802">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/6931956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e2025 class=n-a></a>Ramesh S, Morrell CN, Tarango C, <i> et al.</i>: Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via beta2GPI and apoER2. <i>J Clin Invest.</i> 2011; <b>121</b>(1): 12031. <a target=xrefwindow id=d25091e2036 href="http://www.ncbi.nlm.nih.gov/pubmed/21123944">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2039 href="http://dx.doi.org/10.1172/JCI39828">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2043 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3007129">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/6931956">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d25091e2056 class=n-a></a>Romay-Penabad Z, Aguilar-Valenzuela R, Urbanus RT, <i> et al.</i>: Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. <i>Blood.</i> 2011; <b>117</b>(4): 140814. <a target=xrefwindow id=d25091e2067 href="http://www.ncbi.nlm.nih.gov/pubmed/21119114">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2070 href="http://dx.doi.org/10.1182/blood-2010-07-299099">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2074 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3320849">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725854041"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e2083 class=n-a></a>Ulrich V, Gelber SE, Vukelic M, <i> et al.</i>: ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice. <i>Arthritis Rheumatol.</i> 2016; <b>68</b>(3): 7309. <a target=xrefwindow id=d25091e2094 href="http://www.ncbi.nlm.nih.gov/pubmed/26474194">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2097 href="http://dx.doi.org/10.1002/art.39453">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2101 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4767551">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725854041">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d25091e2115 class=n-a></a>Pennings MT, van Lummel M, Derksen RH, <i> et al.</i>: Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family. <i>J Thromb Haemost.</i> 2006; <b>4</b>(8): 168090. <a target=xrefwindow id=d25091e2126 href="http://www.ncbi.nlm.nih.gov/pubmed/16879209">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2129 href="http://dx.doi.org/10.1111/j.1538-7836.2006.02036.x">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d25091e2138 class=n-a></a>Moestrup SK, Schousboe I, Jacobsen C, <i> et al.</i>: beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. <i>J Clin Invest.</i> 1998; <b>102</b>(5): 9029. <a target=xrefwindow id=d25091e2149 href="http://www.ncbi.nlm.nih.gov/pubmed/9727058">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2152 href="http://dx.doi.org/10.1172/JCI3772">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2156 href="http://www.ncbi.nlm.nih.gov/pmc/articles/508955">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d25091e2165 class=n-a></a>Satta N, Kruithof EK, Fickentscher C, <i> et al.</i>: Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. <i>Blood.</i> 2011; <b>117</b>(20): 552331. <a target=xrefwindow id=d25091e2176 href="http://www.ncbi.nlm.nih.gov/pubmed/21330474">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2179 href="http://dx.doi.org/10.1182/blood-2010-11-316158">Publisher Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d25091e2188 class=n-a></a>Alard J, Gaillard F, Daridon C, <i> et al.</i>: TLR2 is one of the endothelial receptors for beta 2-glycoprotein I. <i>J Immunol.</i> 2010; <b>185</b>(3): 15507. <a target=xrefwindow id=d25091e2199 href="http://www.ncbi.nlm.nih.gov/pubmed/20601596">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2202 href="http://dx.doi.org/10.4049/jimmunol.1000526">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d25091e2211 class=n-a></a>Pierangeli SS, Vega-Ostertag ME, Raschi E, <i> et al.</i>: Toll-like receptor and antiphospholipid mediated thrombosis: <i>in vivo</i> studies. <i>Ann Rheum Dis.</i> 2007; <b>66</b>(10): 132733. <a target=xrefwindow id=d25091e2225 href="http://www.ncbi.nlm.nih.gov/pubmed/17261530">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2229 href="http://dx.doi.org/10.1136/ard.2006.065037">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2232 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1994302">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d25091e2241 class=n-a></a>Shi T, Giannakopoulos B, Yan X, <i> et al.</i>: Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. <i>Arthritis Rheum.</i> 2006; <b>54</b>(8): 255867. <a target=xrefwindow id=d25091e2252 href="http://www.ncbi.nlm.nih.gov/pubmed/16868978">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2255 href="http://dx.doi.org/10.1002/art.21968">Publisher Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d25091e2265 class=n-a></a>Urbanus RT, Pennings MT, Derksen RH, <i> et al.</i>: Platelet activation by dimeric beta2-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2'. <i>J Thromb Haemost.</i> 2008; <b>6</b>(8): 140512. <a target=xrefwindow id=d25091e2276 href="http://www.ncbi.nlm.nih.gov/pubmed/18485085">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2279 href="http://dx.doi.org/10.1111/j.1538-7836.2008.03021.x">Publisher Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d25091e2288 class=n-a></a>Sikara MP, Routsias JG, Samiotaki M, <i> et al.</i>: {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome. <i>Blood.</i> 2010; <b>115</b>(3): 71323. <a target=xrefwindow id=d25091e2299 href="http://www.ncbi.nlm.nih.gov/pubmed/19805618">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2302 href="http://dx.doi.org/10.1182/blood-2009-03-206367">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d25091e2311 class=n-a></a>Poulton K, Rahman A, Giles I: Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review. <i>Semin Arthritis Rheum.</i> 2012; <b>41</b>(5): 72036. <a target=xrefwindow id=d25091e2319 href="http://www.ncbi.nlm.nih.gov/pubmed/22055541">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2322 href="http://dx.doi.org/10.1016/j.semarthrit.2011.09.004">Publisher Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/727106035"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e2331 class=n-a></a>Canaud G, Bienaim F, Tabarin F, <i> et al.</i>: Inhibition of the mTORC pathway in the antiphospholipid syndrome. <i>N Engl J Med.</i> 2014; <b>371</b>(4): 30312. <a target=xrefwindow id=d25091e2342 href="http://www.ncbi.nlm.nih.gov/pubmed/25054716">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2345 href="http://dx.doi.org/10.1056/NEJMoa1312890">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/727106035">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d25091e2358 class=n-a></a>de Laat B, Eckmann CM, van Schagen M, <i> et al.</i>: Correlation between the potency of a beta2-glycoprotein I-dependent lupus anticoagulant and the level of resistance to activated protein C. <i>Blood Coagul Fibrinolysis.</i> 2008; <b>19</b>(8): 75764. <a target=xrefwindow id=d25091e2369 href="http://www.ncbi.nlm.nih.gov/pubmed/19002041">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2372 href="http://dx.doi.org/10.1097/MBC.0b013e32830f1b85">Publisher Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d25091e2381 class=n-a></a>Galli M, Willems GM, Rosing J, <i> et al.</i>: Anti-prothrombin IgG from patients with anti-phospholipid antibodies inhibits the inactivation of factor Va by activated protein C. <i>Br J Haematol.</i> 2005; <b>129</b>(2): 2407. <a target=xrefwindow id=d25091e2392 href="http://www.ncbi.nlm.nih.gov/pubmed/15813852">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2395 href="http://dx.doi.org/10.1111/j.1365-2141.2005.05438.x">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d25091e2405 class=n-a></a>Patterson AM, Ford I, Graham A, <i> et al.</i>: The influence of anti-endothelial/antiphospholipid antibodies on fibrin formation and lysis on endothelial cells. <i>Br J Haematol.</i> 2006; <b>133</b>(3): 32330. <a target=xrefwindow id=d25091e2416 href="http://www.ncbi.nlm.nih.gov/pubmed/16643435">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2419 href="http://dx.doi.org/10.1111/j.1365-2141.2006.05994.x">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d25091e2428 class=n-a></a>Ieko M, Yoshida M, Naito S, <i> et al.</i>: Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation. <i>Int J Hematol.</i> 2010; <b>91</b>(5): 77683. <a target=xrefwindow id=d25091e2439 href="http://www.ncbi.nlm.nih.gov/pubmed/20490730">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2442 href="http://dx.doi.org/10.1007/s12185-010-0590-0">Publisher Full Text </a></span></li><li><a name=ref-68 class=n-a></a><span class=label>68. </span>&nbsp;<span class=citation><a name=d25091e2451 class=n-a></a>Gombs J, Tanka-Salamon A, Skopl J, <i> et al.</i>: Modulation of fibrinolysis by the combined action of phospholipids and immunoglobulins. <i>Blood Coagul Fibrinolysis.</i> 2008; <b>19</b>(1): 828. <a target=xrefwindow id=d25091e2462 href="http://www.ncbi.nlm.nih.gov/pubmed/18180621">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2465 href="http://dx.doi.org/10.1097/MBC.0b013e3282f38c6f">Publisher Full Text </a></span></li><li><a name=ref-69 class=n-a></a><span class=label>69. </span>&nbsp;<span class=citation><a name=d25091e2474 class=n-a></a>Lpez-Lira F, Rosales-Len L, Martnez VM, <i> et al.</i>: The role of beta2-glycoprotein I (beta2GPI) in the activation of plasminogen. <i>Biochim Biophys Acta.</i> 2006; <b>1764</b>(4): 81523. <a target=xrefwindow id=d25091e2485 href="http://www.ncbi.nlm.nih.gov/pubmed/16480936">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2488 href="http://dx.doi.org/10.1016/j.bbapap.2005.12.020">Publisher Full Text </a></span></li><li><a name=ref-70 class=n-a></a><span class=label>70. </span>&nbsp;<span class=citation><a name=d25091e2497 class=n-a></a>Lean SY, Ellery P, Ivey L, <i> et al.</i>: The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation. <i>Haematologica.</i> 2006; <b>91</b>(10): 13606. <a target=xrefwindow id=d25091e2508 href="http://www.ncbi.nlm.nih.gov/pubmed/17018385">PubMed Abstract </a></span></li><li><a name=ref-71 class=n-a></a><span class=label>71. </span>&nbsp;<span class=citation><a name=d25091e2517 class=n-a></a>Liestl S, Sandset PM, Jacobsen EM, <i> et al.</i>: Decreased anticoagulant response to tissue factor pathway inhibitor type 1 in plasmas from patients with lupus anticoagulants. <i>Br J Haematol.</i> 2007; <b>136</b>(1): 1317. <a target=xrefwindow id=d25091e2528 href="http://www.ncbi.nlm.nih.gov/pubmed/17092306">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2531 href="http://dx.doi.org/10.1111/j.1365-2141.2006.06385.x">Publisher Full Text </a></span></li><li><a name=ref-72 class=n-a></a><span class=label>72. </span>&nbsp;<span class=citation><a name=d25091e2541 class=n-a></a>Rahgozar S, Yang Q, Giannakopoulos B, <i> et al.</i>: Beta<sub>2</sub>-glycoprotein I binds thrombin via exosite I and exosite II: anti-beta<sub>2</sub>-glycoprotein I antibodies potentiate the inhibitory effect of beta<sub>2</sub>-glycoprotein I on thrombin-mediated factor XIa generation. <i>Arthritis Rheum.</i> 2007; <b>56</b>(2): 60513. <a target=xrefwindow id=d25091e2562 href="http://www.ncbi.nlm.nih.gov/pubmed/17265495">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2565 href="http://dx.doi.org/10.1002/art.22367">Publisher Full Text </a></span></li><li><a name=ref-73 class=n-a></a><span class=label>73. </span>&nbsp;<span class=citation><a name=d25091e2574 class=n-a></a>Rahgozar S, Giannakopoulos B, Yan X, <i> et al.</i>: Beta<sub>2</sub>-glycoprotein I protects thrombin from inhibition by heparin cofactor II: potentiation of this effect in the presence of anti-beta<sub>2</sub>-glycoprotein I autoantibodies. <i>Arthritis Rheum.</i> 2008; <b>58</b>(4): 114655. <a target=xrefwindow id=d25091e2592 href="http://www.ncbi.nlm.nih.gov/pubmed/18383370">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2595 href="http://dx.doi.org/10.1002/art.23387">Publisher Full Text </a></span></li><li><a name=ref-74 class=n-a></a><span class=label>74. </span>&nbsp;<span class=citation><a name=d25091e2604 class=n-a></a>de Laat B, Wu XX, van Lummel M, <i> et al.</i>: Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5. <i>Blood.</i> 2007; <b>109</b>(4): 14904. <a target=xrefwindow id=d25091e2615 href="http://www.ncbi.nlm.nih.gov/pubmed/17053060">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2618 href="http://dx.doi.org/10.1182/blood-2006-07-030148">Publisher Full Text </a></span></li><li><a name=ref-75 class=n-a></a><span class=label>75. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/1276956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e2627 class=n-a></a>Rand JH, Wu XX, Quinn AS, <i> et al.</i>: Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. <i>Blood.</i> 2010; <b>115</b>(11): 22929. <a target=xrefwindow id=d25091e2638 href="http://www.ncbi.nlm.nih.gov/pubmed/19965621">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2641 href="http://dx.doi.org/10.1182/blood-2009-04-213520">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2645 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2844013">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/1276956">F1000 Recommendation</a></span></li><li><a name=ref-76 class=n-a></a><span class=label>76. </span>&nbsp;<span class=citation><a name=d25091e2658 class=n-a></a>Hunt BJ, Wu XX, de Laat B, <i> et al.</i>: Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome. <i>Am J Obstet Gynecol.</i> 2011; <b>205</b>(5): 485.e1723. <a target=xrefwindow id=d25091e2669 href="http://www.ncbi.nlm.nih.gov/pubmed/21784397">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2672 href="http://dx.doi.org/10.1016/j.ajog.2011.06.019">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2676 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3205287">Free Full Text </a></span></li><li><a name=ref-77 class=n-a></a><span class=label>77. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/13445970"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e2685 class=n-a></a>Wu XX, Guller S, Rand JH: Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression. <i>Am J Obstet Gynecol.</i> 2011; <b>205</b>(6): 576.e714. <a target=xrefwindow id=d25091e2693 href="http://www.ncbi.nlm.nih.gov/pubmed/21871597">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2696 href="http://dx.doi.org/10.1016/j.ajog.2011.06.064">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2699 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3224185">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/13445970">F1000 Recommendation</a></span></li><li><a name=ref-78 class=n-a></a><span class=label>78. </span>&nbsp;<span class=citation><a name=d25091e2713 class=n-a></a>Gropp K, Weber N, Reuter M, <i> et al.</i>: <sub>2</sub>-glycoprotein I, the major target in antiphospholipid syndrome, is a special human complement regulator. <i>Blood.</i> 2011; <b>118</b>(10): 277483. <a target=xrefwindow id=d25091e2727 href="http://www.ncbi.nlm.nih.gov/pubmed/21757614">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2731 href="http://dx.doi.org/10.1182/blood-2011-02-339564">Publisher Full Text </a></span></li><li><a name=ref-79 class=n-a></a><span class=label>79. </span>&nbsp;<span class=citation><a name=d25091e2740 class=n-a></a>Otomo K, Atsumi T, Amengual O, <i> et al.</i>: Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. <i>Arthritis Rheum.</i> 2012; <b>64</b>(2): 50412. <a target=xrefwindow id=d25091e2751 href="http://www.ncbi.nlm.nih.gov/pubmed/21953404">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2754 href="http://dx.doi.org/10.1002/art.33340">Publisher Full Text </a></span></li><li><a name=ref-80 class=n-a></a><span class=label>80. </span>&nbsp;<span class=citation><a name=d25091e2763 class=n-a></a>Sciascia S, Sanna G, Murru V, <i> et al.</i>: GAPSS: the Global Anti-Phospholipid Syndrome Score. <i>Rheumatology (Oxford).</i> 2013; <b>52</b>(8): 1397403. <a target=xrefwindow id=d25091e2774 href="http://www.ncbi.nlm.nih.gov/pubmed/23315788">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2777 href="http://dx.doi.org/10.1093/rheumatology/kes388">Publisher Full Text </a></span></li><li><a name=ref-81 class=n-a></a><span class=label>81. </span>&nbsp;<span class=citation><a name=d25091e2786 class=n-a></a>Sciascia S, Bertolaccini ML, Roccatello D, <i> et al.</i>: Independent validation of the antiphospholipid score for the diagnosis of antiphospholipid syndrome. <i>Ann Rheum Dis.</i> 2013; <b>72</b>(1): 1423. <a target=xrefwindow id=d25091e2797 href="http://www.ncbi.nlm.nih.gov/pubmed/22843492">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2800 href="http://dx.doi.org/10.1136/annrheumdis-2012-201985">Publisher Full Text </a></span></li><li><a name=ref-82 class=n-a></a><span class=label>82. </span>&nbsp;<span class=citation><a name=d25091e2809 class=n-a></a>Bertolaccini ML, Amengual O, Atsumi T, <i> et al.</i>: 'Non-criteria' aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. <i>Lupus.</i> 2011; <b>20</b>(2): 191205. <a target=xrefwindow id=d25091e2820 href="http://www.ncbi.nlm.nih.gov/pubmed/21303836">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2823 href="http://dx.doi.org/10.1177/0961203310397082">Publisher Full Text </a></span></li><li><a name=ref-83 class=n-a></a><span class=label>83. </span>&nbsp;<span class=citation><a name=d25091e2832 class=n-a></a>Sciascia S, Cuadrado MJ, Sanna G, <i> et al.</i>: Prospective validation of the Global AntiPhospholpid Syndrome Score (GAPSS). <i>Arthritis Rheum.</i> 2013; <b>65</b>: S3. </span></li><li><a name=ref-84 class=n-a></a><span class=label>84. </span>&nbsp;<span class=citation><a name=d25091e2851 class=n-a></a>Sciascia S, Sanna G, Murru V, <i> et al.</i>: The global anti-phospholipid syndrome score in primary APS. <i>Rheumatology (Oxford).</i> 2015; <b>54</b>(1): 1348. <a target=xrefwindow id=d25091e2862 href="http://www.ncbi.nlm.nih.gov/pubmed/25122726">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2865 href="http://dx.doi.org/10.1093/rheumatology/keu307">Publisher Full Text </a></span></li><li><a name=ref-85 class=n-a></a><span class=label>85. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/725639886"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d25091e2874 class=n-a></a>Zuily S, de Laat B, Mohamed S, <i> et al.</i>: Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study. <i>Rheumatology (Oxford).</i> 2015; <b>54</b>(11): 20715. <a target=xrefwindow id=d25091e2885 href="http://www.ncbi.nlm.nih.gov/pubmed/26163690">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2888 href="http://dx.doi.org/10.1093/rheumatology/kev238">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/725639886">F1000 Recommendation</a></span></li><li><a name=ref-86 class=n-a></a><span class=label>86. </span>&nbsp;<span class=citation><a name=d25091e2901 class=n-a></a>Oku K, Amengual O, Bohgaki T, <i> et al.</i>: An independent validation of the Global Anti-Phospholipid Syndrome Score in a Japanese cohort of patients with autoimmune diseases. <i>Lupus.</i> 2015; <b>24</b>(7): 7745. <a target=xrefwindow id=d25091e2912 href="http://www.ncbi.nlm.nih.gov/pubmed/25432782">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2915 href="http://dx.doi.org/10.1177/0961203314561284">Publisher Full Text </a></span></li><li><a name=ref-87 class=n-a></a><span class=label>87. </span>&nbsp;<span class=citation><a name=d25091e2924 class=n-a></a>Aggarwal R, Ringold S, Khanna D, <i> et al.</i>: Distinctions between diagnostic and classification criteria? <i>Arthritis Care Res (Hoboken).</i> 2015; <b>67</b>(7): 8917. <a target=xrefwindow id=d25091e2935 href="http://www.ncbi.nlm.nih.gov/pubmed/25776731">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2938 href="http://dx.doi.org/10.1002/acr.22583">Publisher Full Text </a> | <a target=xrefwindow id=d25091e2942 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4482786">Free Full Text </a></span></li><li><a name=ref-88 class=n-a></a><span class=label>88. </span>&nbsp;<span class=citation><a name=d25091e2951 class=n-a></a>Barbhaiya M, Erkan D: Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand? <i>Curr Rheumatol Rep.</i> 2011; <b>13</b>(1): 5969. <a target=xrefwindow id=d25091e2959 href="http://www.ncbi.nlm.nih.gov/pubmed/21104348">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2962 href="http://dx.doi.org/10.1007/s11926-010-0149-3">Publisher Full Text </a></span></li><li><a name=ref-89 class=n-a></a><span class=label>89. </span>&nbsp;<span class=citation><a name=d25091e2971 class=n-a></a>Shah NM, Khamashta MA, Atsumi T, <i> et al.</i>: Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients. <i>Lupus.</i> 1998; <b>7</b>(1): 36. <a target=xrefwindow id=d25091e2982 href="http://www.ncbi.nlm.nih.gov/pubmed/9493141">PubMed Abstract </a> | <a target=xrefwindow id=d25091e2985 href="http://dx.doi.org/10.1191/096120398678919624">Publisher Full Text </a></span></li><li><a name=ref-90 class=n-a></a><span class=label>90. </span>&nbsp;<span class=citation><a name=d25091e2995 class=n-a></a>Girn-Gonzlez JA, Garca del Ro E, Rodrguez C, <i> et al.</i>: Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. <i>J Rheumatol.</i> 2004; <b>31</b>(8): 15607. <a target=xrefwindow id=d25091e3006 href="http://www.ncbi.nlm.nih.gov/pubmed/15290736">PubMed Abstract </a></span></li><li><a name=ref-91 class=n-a></a><span class=label>91. </span>&nbsp;<span class=citation><a name=d25091e3015 class=n-a></a>Erkan D, Harrison MJ, Levy R, <i> et al.</i>: Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. <i>Arthritis Rheum.</i> 2007; <b>56</b>(7): 238291. <a target=xrefwindow id=d25091e3026 href="http://www.ncbi.nlm.nih.gov/pubmed/17599766">PubMed Abstract </a> | <a target=xrefwindow id=d25091e3029 href="http://dx.doi.org/10.1002/art.22663">Publisher Full Text </a></span></li><li><a name=ref-92 class=n-a></a><span class=label>92. </span>&nbsp;<span class=citation><a name=d25091e3038 class=n-a></a>Ruffatti A, Del Ross T, Ciprian M, <i> et al.</i>: Risk factors for a first thrombotic event in antiphospholipid antibody carriers: a prospective multicentre follow-up study. <i>Ann Rheum Dis.</i> 2011; <b>70</b>(6): 10836. <a target=xrefwindow id=d25091e3049 href="http://www.ncbi.nlm.nih.gov/pubmed/21285115">PubMed Abstract </a> | <a target=xrefwindow id=d25091e3052 href="http://dx.doi.org/10.1136/ard.2010.142042">Publisher Full Text </a></span></li><li><a name=ref-93 class=n-a></a><span class=label>93. </span>&nbsp;<span class=citation><a name=d25091e3061 class=n-a></a>Cuadrado MJ, Bertolaccini ML, Seed PT, <i> et al.</i>: Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS). <i>Rheumatology (Oxford).</i> 2014; <b>53</b>(2): 27584. <a target=xrefwindow id=d25091e3072 href="http://www.ncbi.nlm.nih.gov/pubmed/24097288">PubMed Abstract </a> | <a target=xrefwindow id=d25091e3075 href="http://dx.doi.org/10.1093/rheumatology/ket313">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 22 Dec 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2908&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2908&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Academic Department of Vascular Surgery, Cardiovascular Division, King&rsquo;s College London, London, UK<br/> <sup>2</sup> Louise Coote Lupus Unit, Guy's and St Thomas' NHS Foundation Trust, London, UK<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/5-2908/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 22 Dec 2016, 5:2908 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.9717.1">https://doi.org/10.12688/f1000research.9717.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2016 Bertolaccini ML and Sanna G. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=10474 data-id=9717 data-downloads="" data-views="" data-scholar="10.12688/f1000research.9717.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/5-2908/v1/pdf?article_uuid=0527e58a-c657-444b-ad18-e25b752ca9e7" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.9717.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Bertolaccini ML and Sanna G. Recent advances in understanding antiphospholipid syndrome [version 1; peer review: 2 approved] <i>F1000Research</i> 2016, <b>5</b>(F1000 Faculty Rev):2908 (<a href="https://doi.org/10.12688/f1000research.9717.1" target=_blank>https://doi.org/10.12688/f1000research.9717.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=9717 id=mobile-track-article-signin-9717 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/9717?target=/articles/5-2908"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=10474 /> <input name=articleId type=hidden value=9717 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Imad Uthman</strong>, Division of Rheumatology, American University of Beirut, Lebanon </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Michael D Lockshin</strong>, Hospital for Special Surgery, Weill Cornell Medical College, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 22 Dec 2016</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/5-2908&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/5-2908&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=19148-18743></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=19149-18744></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/5-2908/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>22 Dec 16</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Imad Uthman</strong>, Division of Rheumatology, American University of Beirut, Lebanon </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Michael D Lockshin</strong>, Hospital for Special Surgery, Weill Cornell Medical College, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/5-2908&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/5-2908/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in understanding antiphospholipid...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/5-2908/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/5-2908/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/5-2908/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Bertolaccini ML and Sanna G');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/5-2908/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/5-2908",
            templates : {
                twitter : "Recent advances in understanding antiphospholipid syndrome. Bertolaccini ML and Sanna G, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/5-2908/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in understanding antiphospholipid syndrome", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in understanding antiphospholipid syndrome", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/9717/10474")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "10474");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "18743": 0,
                           "18744": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "f787326e-68bd-4a5a-b05f-fdc0bf84c65e";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2908.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2908.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/5-2908.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/5-2908.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/5-2908.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>